TB stigma varies widely across South African communities

Tuberculosis (TB) remains a major public health challenge in South Africa, and stigma around the disease can keep people from seeking diagnosis and treatment. In a new community-level look at this problem, Aaron M. Kipp and colleagues set out to measure how TB-related stigma differs across neighborhoods and towns. Rather than focusing only on individual attitudes, the team captured perceptions at the community level across the Buffalo City Metropolitan Health District. They carried out the work as part of the MISSED TB Outcomes Study, sampling households in geographically clustered random samples within clearly demarcated study communities. By surveying heads of household (HoHs) using established questionnaires, the researchers aimed to quantify what it feels like to live in a place where TB is stigmatized, and to compare levels of stigma in urban, peri-urban, and rural settings. This community-centered approach lets public health planners see where stigma is most concentrated and how it relates to other local factors, rather than assuming the same barriers exist everywhere.

The study surveyed 3,869 households across 93 communities and used validated scales to measure perceived community-level TB stigma, HIV stigma, and TB/HIV knowledge. Heads of household provided demographic details and self-reported household TB and HIV history, and individual responses were aggregated to produce community-level measures for each study area. The investigators compared median community TB stigma scores by community location and used robust linear regression to explore associations between TB stigma and other community-level variables. Their analysis found meaningful differences by setting: rural communities reported the lowest median TB stigma scores while peri-urban communities reported the highest. Across all community types, TB stigma was positively associated with HIV stigma, with the strongest links observed in urban and rural areas. After adjusting for community location, the team did not find associations between TB stigma and TB prevalence, TB knowledge, or household demographics.

These findings shift attention from individual-level education or disease burden alone to the broader social context where people live. Because TB stigma varied across communities and was tied to local patterns of HIV stigma and urbanicity, the study suggests that one-size-fits-all stigma-reduction programs are unlikely to work everywhere. Instead, interventions should be tailored to local contexts, taking into account community-level drivers and the neighborhood or town's social fabric. Importantly, the lack of a link between stigma and TB knowledge implies that simply increasing factual information about TB may not reduce community stigma. The documented variability will also help shape future multilevel analyses of the TB care cascade in South Africa, guiding where to focus efforts to remove barriers to timely diagnosis and treatment and to measure how community-level stigma influences care outcomes.